Effect of spironolactone and benazepril on furosemide‐induced diuresis and renin‐angiotensin‐aldosterone system activation in normal dogs

Código QR

Effect of spironolactone and benazepril on furosemide‐induced diuresis and renin‐angiotensin‐aldosterone system activation in normal dogs

Abstract Background Diuretic braking during furosemide continuous rate infusion (FCRI) curtails urine production. Hypothesis Renin‐angiotensin‐aldosterone system (RAAS) activation mediates braking, and RAAS inhibition will increase urine production. Animals Ten healthy purpose‐bred male dogs. Method...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Darcy Adin, Clarke Atkins, Gabrielle Wallace, Allison Klein
Formato:	article
Lenguaje:	EN
Publicado:	Wiley 2021
Materias:	aldosterone antagonist angiotensin‐converting enzyme inhibitor continuous rate infusion diuretic resistance neurohormone urine production Veterinary medicine SF600-1100
Acceso en línea:	https://doaj.org/article/789a23e51ed64ded8d8076212e8a2245
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Hiperaldosteronismo primario y embarazo: Lecciones obtenidas de 2 casos clínicos
por: Germain A,Alfredo M, et al.
Publicado: (2002)

Editorial: New Trends in the Renin-Angiotensin-Aldosterone System in Cardiovascular Disease
por: Ewa Szczepanska-Sadowska, et al.
Publicado: (2021)

Tactics of antihypertensive therapy during COVID-19 pandemic
por: Valery I. Podzolkov, et al.
Publicado: (2021)

Genetic polymorphism of renin-angiotensin-aldosterone system in type 2 diabetes and in combination with arterial hypertension among Dagestan inhabitants
por: Marat Z. Saidov, et al.
Publicado: (2019)

The role of the tissue renin-angiotensin-aldosterone system in the development of metabolic syndrome, diabetes mellitus and itsvascular complications
por: Marina Vladimirovna Shestakova
Publicado: (2010)

Corpus luteum number and the maternal renin-angiotensin-aldosterone system as determinants of utero-placental (vascular) development: the Rotterdam Periconceptional Cohort
por: Rosalieke E. Wiegel, et al.
Publicado: (2021)

Effect of Angiotensin–Neprilysin Versus Renin–Angiotensin System Inhibition on Renal Outcomes: A Systematic Review and Meta-Analysis
por: Ying Xu, et al.
Publicado: (2021)

Epigenetic Regulation of Aldosterone Synthase Gene by Sodium and Angiotensin <styled-content style="fixed-case">II</styled-content>
por: Yoshimichi Takeda, et al.
Publicado: (2018)

Renin-angiotensin-aldosterone system in the elderly: rational use of aliskiren in managing hypertension
por: Karl Andersen
Publicado: (2009)

Hipertensión arterial resistente
por: Feldstein,Carlos A
Publicado: (2008)

Polymorphism of genes-candidates of renin-angiotensin-aldosteronovy system (ACE, AGT, AGTR1) and effectiveness of treatment of arterial hypertension. Results of research in Mountain Shoria
por: Tatyana A. Mulerova, et al.
Publicado: (2021)

The role of renin-angiotensin system and angiotensin-converting enzyme 2 (ACE2) in the development and course of viral infection COVID-19 in patients with diabetes mellitus
por: O. K. Vikulova, et al.
Publicado: (2020)

Aplicaciones y proyecciones de los antagonistas del receptor de mineralocorticoides en el tratamiento de patologías cardiovasculares
por: Verdugo,Fernando J, et al.
Publicado: (2014)

Relationship between the expression of angiotensin II receptors type 1 and vasoactive regulators in arterial hypertension
por: Anna V. Logatkina, et al.
Publicado: (2020)

Actividad de 11 beta hidroxiesteroide dehidrogenasa tipo 2 en hipertensos chilenos
por: Mosso G,Lorena, et al.
Publicado: (2002)

Angiotensin II and the Renal Hemodynamic Response to an Isolated Increased Renal Venous Pressure in Rats
por: Xiaohua Huang, et al.
Publicado: (2021)

Reply to Siniorakis et al., “COVID-19 Interference with Renin-Angiotensin System in the Context of Heart Failure”
por: David S. Fedson, et al.
Publicado: (2020)

Effect of Angiotensin-Converting-Enzyme Inhibitor and Angiotensin II Receptor Antagonist Treatment on ACE2 Expression and SARS-CoV-2 Replication in Primary Airway Epithelial Cells
por: Oghenemega Okoloko, et al.
Publicado: (2021)

Alternative renin-angiotensin system pathways in adipose tissue and their role in the pathogenesis of obesity
por: Slamkova M, et al.
Publicado: (2016)

Effect of telmisartan, angiotensin‐converting enzyme inhibition, or both, on proteinuria and blood pressure in dogs
por: Brittany L. Fowler, et al.
Publicado: (2021)

Endoplasmic Reticulum (ER) Stress in Part Mediates Effects of Angiotensin II in Pancreatic Beta Cells
por: Ramalingam L, et al.
Publicado: (2020)

Circulating microRNAs as Diagnostic Markers in Primary Aldosteronism
por: Scott M. MacKenzie, et al.
Publicado: (2021)

El efecto anti-hipertensivo de Angiotensina-(1-9) es mediado por aumento temprano de la diuresis y natriuresis
por: Moya,Jackeline, et al.
Publicado: (2015)

The Renin–Angiotensin–Aldosterone System and Coronavirus Disease 2019
por: Eliecer Coto, et al.
Publicado: (2021)

Decongestive diuresis using combination intravenous loop diuretics plus chlorothiazide in type 1 acute cardiorenal syndrome and worsening acute kidney injury; a neglected paradigm in resource-poor settings
por: Macaulay Amechi Chukwukadibia Onuigbo
Publicado: (2020)

Efectividad del uso combinado de un inhibidor de Rho Kinasa y de un antagonista del receptor de angiotensina II en la prevención de hipertrofia ventricular en ratas hipertensas
por: Novoa,Ulises, et al.
Publicado: (2010)

Progress on Genetic Basis of Primary Aldosteronism
por: Izabela Karwacka, et al.
Publicado: (2021)

A short review of primary aldosteronism in a question and answer fashion
por: Farrugia Frederick-Anthony, et al.
Publicado: (2018)

Signal Transduction of Mineralocorticoid and Angiotensin II Receptors in the Central Control of Sodium Appetite: A Narrative Review
por: Michele Iovino, et al.
Publicado: (2021)

A Prospective Comparative Study on Cardiac Alterations After Surgery and Drug Treatment of Primary Aldosteronism
por: Yi-Lin Chen, et al.
Publicado: (2021)

New clinical opportunities for mineralocorticoid receptor antagonists: focus on antifibrotic effects
por: Natalia A. Dragomiretskaya, et al.
Publicado: (2021)

Transcriptomics, Epigenetics, and Metabolomics of Primary Aldosteronism
por: Ariadni Spyroglou, et al.
Publicado: (2021)

Enhanced Thrombotic Responses Are Associated With Striatin Deficiency and Aldosterone
por: Anna Gromotowicz‐Poplawska, et al.
Publicado: (2021)

COVID-19 pathophysiology may be driven by an imbalance in the renin-angiotensin-aldosterone system
por: Susanne Rysz, et al.
Publicado: (2021)

Mitochondria-Endoplasmic Reticulum Crosstalk in Parkinson’s Disease: The Role of Brain Renin Angiotensin System Components
por: Tuladhar Sunanda, et al.
Publicado: (2021)

A local renal renin–angiotensin system activation via renal uptake of prorenin and angiotensinogen in diabetic rats
por: Tojo A, et al.
Publicado: (2016)

Russian Medical Society for Arterial Hypertension Expert Consensus: Hypertension and COVID-19
por: Irina E. Chazova, et al.
Publicado: (2020)

Moderate Intensity Aerobic Exercise Potential Favorable Effect Against COVID-19: The Role of Renin-Angiotensin System and Immunomodulatory Effects
por: Hamid Arazi, et al.
Publicado: (2021)

New perspectives in the renin-angiotensin-aldosterone system (RAAS) I: endogenous angiotensin converting enzyme (ACE) inhibition.
por: Miklós Fagyas, et al.
Publicado: (2014)

Renin-angiotensin system inhibitor attenuates oxidative stress induced human coronary artery endothelial cell dysfunction via the PI3K/AKT/mTOR pathway
por: Xuekun Shi, et al.
Publicado: (2018)